Skip to content

Aptera Motors Corp. SEV Stockbased Compensation For Issuance Costs

Stockbased Compensation For Issuance Costs at other companies

GSI Technology logo
GSI TechnologyGSIT
$707.5K
Preformed Line Products logo
Preformed Line ProductsPLPC
$3.94M+3.6%
Rayonier Advanced Materials logo
Rayonier Advanced MaterialsRYAM
$0-100%
Apyx Medical Corporation logo
Apyx Medical CorporationAPYX
$62K+10.7%
KEE
Keel Infrastructure Corp. Common StockKEEL
$58K
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$993K

Other financials

Income statement

See full
Operating income-$10.3M+7.4%
Net income-$10.2M+6.2%
EPS (diluted)-$0.32+30.4%

Balance sheet

See full
Cash & equivalents$17.7M+64.9%
Total debt$2.3M
Total equity$29.6M+27.5%
Total assets$39.0M

Cash flow

See full
Operating cash flow-$7.9M-122%
CapEx$39.0K+290%
Free cash flow-$7.9M-122%

Valuation

See full
Market cap$89.8M-50.7%
Enterprise value$74.4M

Returns & leverage

See full
Return on equity-163.5%+50.9pp
Debt / equity0.1×
Current ratio2.2×

Where this comes from

Reported directly by Aptera Motors Corp. in its filing.

Tagged under the XBRL concept SEV:StockbasedCompensationForIssuanceCosts.

The official record: Aptera Motors Corp. ’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aptera Motors Corp. 's stockbased compensation for issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aptera Motors Corp. 's stockbased compensation for issuance costs?
Aptera Motors Corp. (SEV) reported stockbased compensation for issuance costs of $93.75K in Q4 2025.
What does stockbased compensation for issuance costs mean?
This metric quantifies the portion of equity-based compensation issued specifically to cover costs associated with capital raising activities. It provides transparency into how the company uses equity as a non-cash substitute for service payments related to financing. This helps investors assess the true cost of capital and potential dilution beyond cash-based expenses.